| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents |
| 01/23/2007 | CA2407325C Low ionic strength ophthalmic compositions |
| 01/23/2007 | CA2345466C Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 01/18/2007 | WO2007008926A1 Isoquinoline compounds |
| 01/18/2007 | WO2007008206A1 Dilution resistant viscoelastic compositions |
| 01/18/2007 | WO2007007894A1 Eye drop preparation comprising xanthan gum and terpenoid |
| 01/18/2007 | WO2007007851A1 Percutaneously absorptive ophthalmic preparation comprising epinastine |
| 01/18/2007 | WO2007007737A1 Agent for prevention or treatment of glaucoma |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007006672A1 Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases |
| 01/18/2007 | WO2007006484A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | WO2007006232A1 Hyaluronic acid phospholipid complex and preparing method thereof |
| 01/18/2007 | WO2006127121A3 Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use |
| 01/18/2007 | WO2006121822B1 USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA |
| 01/18/2007 | WO2006107902A9 Use of spirostenols to treat mitochondrial disorders |
| 01/18/2007 | WO2006055526A3 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 01/18/2007 | WO2006042104A3 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/18/2007 | US20070016074 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening |
| 01/18/2007 | US20070015820 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015765 5-(2-pyrazinyl)-4methyl-1,2-dithiol-3-thione (Oltipraz) and its metabolites; neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070014861 Treatment of proctitis |
| 01/18/2007 | US20070014860 Treatment of esophagitis |
| 01/18/2007 | CA2613976A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/17/2007 | EP1743945A1 Screening method |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742638A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye |
| 01/17/2007 | EP1742610A1 Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer |
| 01/17/2007 | EP1480970B1 Quinoline derivatives |
| 01/17/2007 | EP1283047B1 Method for producing a bioactive substance from blood serum |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1897972A Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 01/17/2007 | CN1896096A Production of high-activity extrasin beta 4 derivative by gene engineering |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895648A Chinese-medicine for treating cataracta ophthalmopathy |
| 01/17/2007 | CN1895552A Preparation of compound mixture and its inspection |
| 01/17/2007 | CN1895527A Ear-stabilizing decoction |
| 01/17/2007 | CN1895514A Medicine for treating behcet's syndrome |
| 01/17/2007 | CN1895467A Decoction medicine for treating acute otitis media and its preparation |
| 01/17/2007 | CN1895426A Vision-improving electuary |
| 01/17/2007 | CN1895399A Chinese-medicinal preparation for treating early diabetic retinopathy |
| 01/17/2007 | CN1895284A Gel for removing ocular by ice pearl and its preparation |
| 01/17/2007 | CN1895281A Chinese-medicinal preparation and making method for treating acute corneitis and releasing visual fatigue |
| 01/17/2007 | CN1895253A Lomesaline hydrochloride eye drops and preparation thereof |
| 01/17/2007 | CN1895238A Protection of dithiothreitol for crystal protein and use thereof |
| 01/17/2007 | CN1895219A Bendalysine eye gel preparation and its making method |
| 01/17/2007 | CN1895218A Pyrrolechrisxi and its sodium-salt eye-gel preparation and its making method |
| 01/17/2007 | CN1295332C Recombinant human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1294955C External use traditional Chinese medicine for treating tympanitis |
| 01/17/2007 | CN1294935C Chinese herb medicines for treating cataract |
| 01/17/2007 | CN1294911C Tetrandrine preparation for eyes |
| 01/17/2007 | CN1294909C Novel anti-biological cell free-radical oxidation injury mixture |
| 01/16/2007 | US7163960 Treatment and prevention of inflammatory disorders |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163704 Injection made from Ixeris Sonchifolia Hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof |
| 01/16/2007 | CA2350713C Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body |
| 01/16/2007 | CA2272308C Use of low molecular weight amino alcohols in ophthalmic compositions |
| 01/16/2007 | CA2190303C Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom |
| 01/16/2007 | CA2174449C R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 01/16/2007 | CA2154533C Opthalmic preparation for use as artificial tear |
| 01/11/2007 | WO2007005856A1 Use of hyaluronidase in combination with plasmin for the induction of posterior vitreous detachment |
| 01/11/2007 | WO2007005300A2 Treatment of dry eye |
| 01/11/2007 | WO2007005176A1 Pyrrolidinones for the treatment of glaucoma and ocular hypertension |
| 01/11/2007 | WO2007005174A2 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 01/11/2007 | WO2007003481A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 01/11/2007 | WO2006124780A3 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
| 01/11/2007 | WO2006116950A3 A composition, its preparation method and its use |
| 01/11/2007 | WO2006076370A3 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 01/11/2007 | WO2006072792A3 Compounds which bind to the active site of protein kinase enzymes |
| 01/11/2007 | US20070010581 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 01/11/2007 | US20070010554 Aryl substituted pyridines and the use thereof |
| 01/11/2007 | US20070010534 Novel compounds |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010491 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010430 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | CA2650656A1 Cytokine receptor modulators and uses thereof |
| 01/11/2007 | CA2613464A1 Treatment of dry eye |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740218A1 Materials for treating vascular leakage in the eye |
| 01/10/2007 | EP1740203A1 Polypeptide inducing the secretion of angiopoietin |
| 01/10/2007 | EP1740198A2 Anti-aging effects of substance p |
| 01/10/2007 | EP1740187A1 Macular edema patient selection method and treatment with eye implant comprising a steroid |
| 01/10/2007 | EP1740186A1 Biodegradable intraocular implants containing prostamides |
| 01/10/2007 | EP1740168A2 Antiprostaglandins for the treatment of ocular pathologies |